Arthrex ACP
We are proud to be the official partners of Arthrex in Iraq, bringing world-class orthopedic and biologic solutions to our healthcare community. Arthrex is a global leader in minimally invasive orthopedic technology, known for its commitment to innovation, quality, and medical education. Among the groundbreaking products we offer are the ACP® and ACP Max™ systems—advanced autologous blood concentrate therapies designed to harness the body’s natural healing capabilities.
The ACP® (Autologous Conditioned Plasma) system is a trusted, double-syringe technology used to prepare platelet-rich plasma (PRP) in a simple, closed, and sterile process. It is widely utilized in sports medicine and orthopedics to promote healing in tendons, ligaments, and joints.
The ACP Max™ system builds on this foundation with a higher concentration of platelets and a more refined separation process, delivering a potent formulation ideal for treating more advanced or chronic conditions. Both systems are safe, efficient, and backed by Arthrex’s years of clinical research and innovation in regenerative medicine.
ACP Max®
As the authorized partners of Arthrex in Iraq, we are pleased to introduce the Arthrex ACP Max®, an advanced autologous blood processing system designed to support the preparation of autologous blood products for use in regenerative medicine and orthopedic applications. Arthrex is a global medical device company specializing in the development of innovative products and technologies for orthopedic surgery and regenerative medicine.
Arthrex ACP Max®: Autologous Blood Processing System
The Arthrex ACP Max® is designed to facilitate the efficient processing of a patient's own blood to prepare an autologous blood product for clinical applications. The system provides healthcare professionals with a practical and standardized approach to blood processing while maintaining a focus on ease of use and procedural efficiency.
The ACP Max® system is designed for use in conjunction with appropriate blood processing procedures and compatible Arthrex components. By enabling the preparation of autologous blood products at the point of care, the system supports clinicians in incorporating biologic approaches into their treatment protocols.
The system is particularly relevant to orthopedic and sports medicine applications, where autologous blood products may be used as part of regenerative treatment strategies. Its design supports efficient handling and processing while helping healthcare professionals integrate autologous biologic treatments into their clinical workflow.
ArthrexAngel® System
Angel® System: Blood Processing System
The Arthrex Angel® System is designed to provide healthcare professionals with a flexible and efficient method for processing a patient's own blood at the point of care. The system uses automated blood processing technology to separate and concentrate specific blood components according to the selected processing protocol.
The Angel® System can be used to prepare autologous blood products with different cellular compositions, allowing healthcare professionals to tailor the processing approach to the intended clinical application. This flexibility makes the system suitable for a variety of regenerative medicine and orthopedic procedures.
By providing point-of-care blood processing, the Angel® System supports the integration of autologous biologic treatments into clinical workflows while offering a controlled and standardized processing approach.
